A detailed history of Massachusetts Financial Services CO transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 598,263 shares of BBIO stock, worth $14.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
598,263
Previous 379,006 57.85%
Holding current value
$14.9 Million
Previous $11.7 Million 29.32%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$23.0 - $31.04 $5.04 Million - $6.81 Million
219,257 Added 57.85%
598,263 $15.2 Million
Q1 2024

May 14, 2024

BUY
$27.35 - $40.45 $10.4 Million - $15.3 Million
379,006 New
379,006 $11.7 Million
Q4 2021

Feb 10, 2022

SELL
$11.38 - $53.41 $5.02 Million - $23.6 Million
-441,288 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$46.87 - $64.24 $273,908 - $375,418
-5,844 Reduced 1.31%
441,288 $20.7 Million
Q2 2021

Aug 13, 2021

SELL
$46.47 - $63.93 $59,713 - $82,150
-1,285 Reduced 0.29%
447,132 $27.3 Million
Q1 2021

May 13, 2021

BUY
$55.47 - $72.35 $1.41 Million - $1.84 Million
25,481 Added 6.02%
448,417 $27.6 Million
Q4 2020

Feb 12, 2021

BUY
$38.38 - $71.11 $299,786 - $555,440
7,811 Added 1.88%
422,936 $30.1 Million
Q3 2020

Nov 12, 2020

SELL
$27.2 - $42.19 $277,331 - $430,169
-10,196 Reduced 2.4%
415,125 $15.6 Million
Q2 2020

Aug 11, 2020

BUY
$22.22 - $35.69 $724,660 - $1.16 Million
32,613 Added 8.3%
425,321 $13.9 Million
Q1 2020

May 14, 2020

BUY
$16.11 - $36.23 $1.27 Million - $2.85 Million
78,754 Added 25.08%
392,708 $11.4 Million
Q4 2019

Feb 13, 2020

BUY
$17.96 - $46.63 $1,724 - $4,476
96 Added 0.03%
313,954 $11 Million
Q3 2019

Nov 05, 2019

SELL
$20.13 - $32.38 $727,538 - $1.17 Million
-36,142 Reduced 10.33%
313,858 $6.74 Million
Q2 2019

Aug 14, 2019

BUY
$26.97 - $27.55 $9.44 Million - $9.64 Million
350,000 New
350,000 $9.44 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.7B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.